News headlines Vertex Pharmaceuticals is experiencing positive momentum driven by an upgrade from Wolfe Research and a strong outlook for its IgA nephropathy treatment. Analysts predict substantial ...
2-Year U.S. Treasury Note Continuous Contract $104.371-0.023-0.02% 5-Year U.S. Treasury Note Continuous Contract $109.141-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $112.188-0.016-0.01 ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback